Long Island Wealth Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Long Island Wealth Management's DGX Position: Q1 2024 in Review
Long Island Wealth Management sold out of Quest Diagnostics (DGX) in Q1 2024, closing a stake of 411 shares — an estimated $57K sold.
Long Island Wealth Management first reported a position in DGX in Q4 2023 and held it in 1 quarter. The position peaked at $57K in Q4 2023. 818 funds tracked by Wall St. Rank hold DGX as of Q1 2024.
- Long Island Wealth Management reported no remaining Quest Diagnostics position as of Q1 2024 after selling out during the quarter.
- Long Island Wealth Management sold 411 Quest Diagnostics shares in Q1 2024, an estimated $57K.
- Long Island Wealth Management first reported a position in Quest Diagnostics in Q4 2023 and held it in 1 quarter.
- Long Island Wealth Management's Quest Diagnostics position peaked at $57K in Q4 2023.
- 818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.
Based on Long Island Wealth Management's 13F filing for Q1 2024, filed 13 May 2024.